-
Likelihood of Approval and Phase Transition Success Rate Model - Laromestrocel in Hypoplastic Left Heart Syndrome
Empower your strategies with our Likelihood of Approval and Phase Transition Success Rate Model - Laromestrocel in Hypoplastic Left Heart Syndrome report and make more profitable business decisions. This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalData’s proprietary machine learning algorithms developed using over 10 years of historical data. Laromestrocel in Hypoplastic Left Heart Syndrome Drug Details: Lomecel-B...
-
Likelihood of Approval and Phase Transition Success Rate Model - TAS-0728 in Endometrial Cancer
Empower your strategies with our Likelihood of Approval and Phase Transition Success Rate Model - TAS-0728 in Endometrial Cancer report and make more profitable business decisions. This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalData’s proprietary machine learning algorithms developed using over 10 years of historical data. TAS-0728 in Endometrial Cancer Drug Details: TAS-0728 is under development for...
-
Likelihood of Approval and Phase Transition Success Rate Model - APG-157 in Recurrent Glioblastoma Multiforme (GBM)
Empower your strategies with our Likelihood of Approval and Phase Transition Success Rate Model - APG-157 in Recurrent Glioblastoma Multiforme (GBM) report and make more profitable business decisions. This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalData’s proprietary machine learning algorithms developed using over 10 years of historical data. APG-157 in Recurrent Glioblastoma Multiforme (GBM) Drug Details: APG-157 is...
-
Likelihood of Approval and Phase Transition Success Rate Model - PTS-500 in Non-Small Cell Lung Cancer
Empower your strategies with our Likelihood of Approval and Phase Transition Success Rate Model - PTS-500 in Non-Small Cell Lung Cancer report and make more profitable business decisions. This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalData’s proprietary machine learning algorithms developed using over 10 years of historical data. PTS-500 in Non-Small Cell Lung Cancer Drug Details: PTS-500...
-
Likelihood of Approval and Phase Transition Success Rate Model - Max-1 in Solid Tumor
Empower your strategies with our Likelihood of Approval and Phase Transition Success Rate Model - Max-1 in Solid Tumor report and make more profitable business decisions. This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalData’s proprietary machine learning algorithms developed using over 10 years of historical data. Max-1 in Solid Tumor Drug Details: Max-1 is under development for the...
-
Likelihood of Approval and Phase Transition Success Rate Model - ABA-101 in Primary Progressive Multiple Sclerosis (PPMS)
Empower your strategies with our Likelihood of Approval and Phase Transition Success Rate Model - ABA-101 in Primary Progressive Multiple Sclerosis (PPMS) report and make more profitable business decisions. This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalData’s proprietary machine learning algorithms developed using over 10 years of historical data. ABA-101 in Primary Progressive Multiple Sclerosis (PPMS) Drug...
-
Likelihood of Approval and Phase Transition Success Rate Model - Amlodipine + Indapamide + Valsartan in Idiopathic (Essential) Hypertension
Empower your strategies with our Likelihood of Approval and Phase Transition Success Rate Model - Amlodipine + Indapamide + Valsartan in Idiopathic (Essential) Hypertension report and make more profitable business decisions. This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalData’s proprietary machine learning algorithms developed using over 10 years of historical data. Amlodipine + Indapamide + Valsartan in...
-
Likelihood of Approval and Phase Transition Success Rate Model - Rifaximin in Irritable Bowel Syndrome
Empower your strategies with our Likelihood of Approval and Phase Transition Success Rate Model - Rifaximin in Irritable Bowel Syndrome report and make more profitable business decisions. This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalData’s proprietary machine learning algorithms developed using over 10 years of historical data. Rifaximin in Irritable Bowel Syndrome Drug Details: rifaximin (NEX-001) is...
-
Likelihood of Approval and Phase Transition Success Rate Model - IMC-2015 in Osteonecrosis
Empower your strategies with our Likelihood of Approval and Phase Transition Success Rate Model - IMC-2015 in Osteonecrosis report and make more profitable business decisions. This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalData’s proprietary machine learning algorithms developed using over 10 years of historical data. IMC-2015 in Osteonecrosis Drug Details: IMC-2015 is under development for the treatment...
-
Likelihood of Approval and Phase Transition Success Rate Model - PRT-3789 in Colorectal Cancer
Empower your strategies with our Likelihood of Approval and Phase Transition Success Rate Model - PRT-3789 in Colorectal Cancer report and make more profitable business decisions. This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalData’s proprietary machine learning algorithms developed using over 10 years of historical data. PRT-3789 in Colorectal Cancer Drug Details: PRT-3789 is under development for...
Sign up to receive regular alerts for our latest analysis and reports. No matter your industry focus, you can keep your finger on the pulse with our timely updates.